Situational Update for Clinicians about Severe Monkeypox Virus Infections

At a glance

During this COCA Call, presenters from CDC, the Los Angeles County Department of Public Health, and Emory University will share an update about people with monkeypox who have severe manifestations of the disease.

Webinar

The fully captioned video and edited transcript will be posted within the next few days.

View Slides

Overview

This COCA Call supports and expands on the Centers for Disease Control (CDC) Health Alert Network (HAN) Health Advisory released on September 29, 2022, about people experiencing severe manifestations of monkeypox and medical countermeasures available to treat people who have monkeypox.

The HAN Health Advisory informs healthcare providers that

  1. Severe manifestations of monkeypox have been observed in the United States in the current outbreak.
  2. People who are immunocompromised due to HIV or other conditions are at higher risk for severe manifestations of monkeypox than people who are immunocompetent.
  3. Because people with HIV-associated immunocompromise are at risk for severe manifestations of monkeypox, the HIV status of all sexually active adults and adolescents with suspected or confirmed monkeypox should be determined.
  4. There are diagnostic and clinical management strategies that may help address severe manifestations of monkeypox.

During this COCA Call, presenters from CDC, the Los Angeles County Department of Public Health, and Emory University will share an update about people with monkeypox who have severe manifestations of the disease. Presenters will also describe the clinical courses of two patients with monkeypox, review interventions to prevent and treat monkeypox with antiviral therapy, discuss updated information about the risk of monkeypox transmission, and provide new guidance on selecting a site on the body when administering the vaccine intradermally.

Presenters

Agam Rao, MD, FIDSA
CAPT, U.S. Public Health Service
Subject Matter Expert, Vaccine Task Force and Clinical Task Force
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention

Caroline Schrodt, MD, MSPH
LCDR, U.S. Public Health Service
Lead, Clinical Escalations Team
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention

Jemma Alarcón, MD, MPH
Los Angeles County Department of Public Health
Epidemic Intelligence Service Officer
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention

Alexandra Dretler, MD
Adjunct Professor
Infectious Diseases
Emory University

Call Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC's role in the topic covered during the presentation.
  3. Describe the topic's implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
  5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.

Additional Resources

Continuing Education

Continuing Education is not offered for this COCA Call.

Target Audience

  • Physicians
  • Nurses
  • Pharmacists
  • Veterinarians
  • Physician Assistants
  • Health Educators
  • Other Clinicians

Additional Information

  • Contact Information: coca@cdc.gov
  • Support/Funding: Centers for Disease Control and Prevention, Emergency Risk Communication Branch
  • Method of Participation: You may participate in the educational activity by viewing the program information above.
Print
Content Source: